KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Notes Payables (2021 - 2025)

Historic Notes Payables for Fulgent Genetics (FLGT) over the last 5 years, with Q3 2025 value amounting to $476000.0.

  • Fulgent Genetics' Notes Payables rose 1553.4% to $476000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $476000.0, marking a year-over-year increase of 1553.4%. This contributed to the annual value of $412000.0 for FY2024, which is 6517.33% down from last year.
  • Per Fulgent Genetics' latest filing, its Notes Payables stood at $476000.0 for Q3 2025, which was up 1553.4% from $476000.0 recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Notes Payables peaked at $6.1 million during Q1 2022, and registered a low of $412000.0 during Q2 2024.
  • Over the past 5 years, Fulgent Genetics' median Notes Payables value was $2.9 million (recorded in 2023), while the average stood at $3.1 million.
  • In the last 5 years, Fulgent Genetics' Notes Payables crashed by 9263.55% in 2024 and then surged by 1553.4% in 2025.
  • Fulgent Genetics' Notes Payables (Quarter) stood at $5.9 million in 2021, then decreased by 4.42% to $5.6 million in 2022, then crashed by 79.02% to $1.2 million in 2023, then crashed by 65.17% to $412000.0 in 2024, then grew by 15.53% to $476000.0 in 2025.
  • Its Notes Payables was $476000.0 in Q3 2025, compared to $476000.0 in Q2 2025 and $476000.0 in Q1 2025.